-
EP3059236
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3059236
| EP3059236 - A new quinoline derivative for use in the treatment and prevention of viral infections [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.08.2017 Database last updated on 15.06.2024 | |
| Former | The application has been published Status updated on 05.04.2017 | Most recent event Tooltip | 11.08.2017 | Application deemed to be withdrawn | published on 13.09.2017 [2017/37] | Applicant(s) | For all designated states ABIVAX 5 rue de la Baume 75008 Paris / FR | For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3, rue Michel-Ange 75794 Paris Cedex 16 / FR | For all designated states Institut Curie 26, rue d'Ulm 75248 Paris Cedex 05 / FR | For all designated states UNIVERSITE DE MONTPELLIER 163 rue Auguste Broussonnet 34090 Montpellier / FR | [2016/34] | Inventor(s) | 01 /
Scherrer, Didier 26 avenue des sabines 34170 CASTELNAU LE LEZ / FR | 02 /
Garcel, Aude 5 avenue Monteroni d'Arbia Le Palais Vinci DO2 34920 LE CRES / FR | 03 /
Campos, Noelie 20, rue des Droits de l'Homme Résidence Villa Borghese A32 34920 LE CRES / FR | 04 /
Tazi, Jamal 4 rue Condorcet 34380 CLAPIERS / FR | 05 /
Vautrin, Audrey 462 avenue de l'Europe (appt B15) 34170 CASTELNAU LE LEZ / FR | 06 /
Mahuteau, Florence 36 avenue Hoche 78470 SAINT REMY LES CHEVREUSES / FR | 07 /
Najman, Romain 29b rue du 11 novembre 1918 94240 L'Hay-les-Roses / FR | 08 /
Fornarelli, Pauline 13 rue des 4 cantons 91140 VILLEBON-SUR-YVETTE / FR | [2016/34] | Representative(s) | Cabinet Nony 11 rue Saint-Georges 75009 Paris / FR | [N/P] |
| Former [2016/34] | Nony 11 rue Saint-Georges 75009 Paris / FR | Application number, filing date | 15305274.1 | 23.02.2015 | [2016/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3059236 | Date: | 24.08.2016 | Language: | EN | [2016/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.06.2015 | Classification | IPC: | C07D405/12 | [2016/34] | CPC: |
C07H17/02 (EP,RU,US);
C07D405/12 (EP,KR,RU,US);
A61K31/4709 (RU);
A61K31/4725 (KR);
A61P31/12 (EP);
A61P31/14 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/34] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Neue Chinolinderivate zur Verwendung bei der Behandlung und Prävention von Virusinfektionen | [2016/34] | English: | A new quinoline derivative for use in the treatment and prevention of viral infections | [2016/34] | French: | Nouveau dérivé de quinoléine pour utilisation dans le traitement et la prévention d'infections virales | [2016/34] | Examination procedure | 25.02.2017 | Application deemed to be withdrawn, date of legal effect [2017/37] | 06.04.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2017/37] | Fees paid | Penalty fee | Additional fee for renewal fee | 28.02.2017 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2015001518 (SPLICOS [FR], et al) [I] 1-7 * compound 90 *; | [A] - LAI-YI WANG ET AL, "Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (20040723), vol. 93, no. 10, doi:10.1002/JPS.20156, ISSN 0022-3549, pages 2448 - 2457, XP009120641 [A] 1-7 * figure 1 * DOI: http://dx.doi.org/10.1002/jps.20156 | [A] - BILODEAU MARK T ET AL, "Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (20040101), vol. 47, no. 25, doi:10.1021/JM049697F, ISSN 0022-2623, pages 6363 - 6372, XP002437591 [A] 1-7 * figure 2 * DOI: http://dx.doi.org/10.1021/jm049697f | by applicant | FR2436786 | FR2627493 | FR2645861 | WO2005023255 | WO2010143169 | WO2012080953 | - BAKKOUR ET AL., PLOS PATHOGENS, (2007), vol. 3, pages 1530 - 1539 | - BOLLENBACK, G.N.; LONG, J.W.; BENJAMIN, D.G.; LINDQUIST, J.A., J. AM. CHEM. SOC., (1955), vol. 77, page 3310 | - PINAR IYODOGAN ET AL., "Current Perspectives on HIV-1 Antiretroviral Drug Resistance", VIRUSES, (2014), vol. 6, pages 4095 - 4139 | - WORCH, R. ET AL., "Specificity of recognition of mRNA 5' cap by human nuclear cap-binding complex", RNA, (2005), vol. 11, pages 1355 - 1363 | - MAZZA ET AL., "Large-scale induced fit recognition of an m(7)GpppG cap analogue by the human nuclear cap-binding complex", EMBO J., (2002), vol. 21, pages 5548 - 5557 | - SCHIRLE ET AL., "Mass spectrometry-based proteomics in preclinical drug discovery", CHEM BIOL., (2012), vol. 19, pages 72 - 84 | - SHEVCHENKO ET AL., "Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels", ANAL. CHEM., (1996), vol. 68, no. 5, pages 850 - 8 | - OLSEN ET AL., "Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap", MOL. CELL. PROTEOMICS, (2005), vol. 4, pages 2010 - 2021 | - MACLEAN ET AL., "Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry", ANAL CHEM, (2010), vol. 82, pages 10116 - 10124 | - MAZZA ET AL., "Crystal structure of the human nuclear cap binding complex", MOL. CELL, (2001), vol. 8, pages 383 - 396 | EP20140306164 | EP20140306166 |